Wednesday, June 2, 2021

After SPAC up, Renovacor staffs up with ex-MyoCardia CMO to lead clinical development

REN-001 is an adeno-associated virus-based gene therapy that targets BAG3-associated dilated cardiomyopathy. The disease has an average onset ...
https://www.google.com/url?rct=j&sa=t&url=https://www.fiercebiotech.com/biotech/after-spac-deal-renovacor-staffs-up-ex-myocardia-cmo-to-lead-clinical-development&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNGglsQu2cXNmfGuGkZSsNFeez8tfA

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...